300485.SZ · 赛升药业
China A-shares · RS rating 16 · As of 2026-10-14
| Price | 8.07 CNY |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 45 / 26 / 24 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 19 / 25 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.2% |
| Distance from 52-week high | +39.5% |
| Market cap (USD) | $617.3M |